Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.
about
In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitorsComparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virusAnti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cellsSynthesis of 3'-(4-nitroimidazol-1-yl)-2',3'-dideoxynucleosides of pyrimidine analogues and their biological evaluation against HIVIn vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDSSensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient miceActivities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitroIn vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infectionsUridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profileAnti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitroEffective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride.Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.Modulation of the haematopoietic toxicity associated with zidovudine in vivo with lithium carbonate.Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis.Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient micePSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replicationInhibition of immune functions by antiviral drugs.Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans.Potent anti-murine cytomegalovirus activity and reduced nephrotoxicity of ganciclovir cyclic phosphonate.Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacyEmergence of aminoglycoside resistance genes aadA and aadE in the genus CampylobacterEffects of antiretroviral dideoxynucleosides on polymorphonuclear leukocyte function.Antiviral therapy: current concepts and practicesEvaluation of Toxicity in Mouse Bone Marrow Progenitor CellsPharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.Cytomegalovirus in transplantation - challenging the status quo.Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovirValganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.Pharmacologic studies of nucleosides active against the human immunodeficiency virus.Recent occurrences in the discovery and development of drugs to treat HIV infections.Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cellsSelective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells.Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes.In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus.Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity.Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis.
P2860
Q28323307-7E7D75DB-E85B-4F63-8140-90F71AC13C35Q28323353-112118AF-DB9D-4D58-971C-5F6FE9FB2C52Q28323830-25DB1CA1-5794-4F1C-AA4E-7E278B054BBAQ28328972-E57DD867-F947-4632-9350-47FCAD397F90Q28333060-A9D61198-78B2-465A-AA2F-DEB008A3B6A4Q28335026-A5A6AEAD-8E89-44C0-AD6F-82BD02F45482Q28335917-882851A3-8CCB-44AB-951C-2B3DE11203EAQ28335926-1905666C-AE23-4DFA-8E76-D780DD33BA9BQ28344285-36DC2A2C-C967-4867-9C30-65B2B844FBD1Q28361147-C23C7CA9-FF9C-48D6-9E62-4A3E8DC7EC66Q28367605-3C21138F-883F-4BAE-844C-53561322F02FQ28369464-5ABA1EC5-3A31-4A7A-9349-E81133CFBFB6Q33350615-305DC31C-6C06-4FA0-855D-C4BCCAAB2850Q33396929-8A7AAFD6-BF97-433A-8021-39D911F13BCCQ33494472-82D5555F-0936-48AC-B468-9B0FA7C922E2Q33741992-C57366AE-69F9-4C65-AF6F-B53E9D73A1ECQ33759331-057EA59E-5DA1-4966-9335-6E78F4A3676CQ34045444-7252702E-1279-4461-A59C-3A9A93C20206Q34264407-C80D2C5F-68F7-4546-BD6F-52CBEEAA87ABQ35118261-C1EC9785-4D91-4E11-BDF5-13677D6E59F1Q35122740-FEEB0C3B-1B31-4F27-8F42-0841CEB2ADD3Q35126399-04D5A04E-AF1E-4AA9-A96B-A39554D497B6Q35127088-B3A49292-B035-44D2-BD84-E73BCEB36483Q35264706-3DB32A69-B51B-4AD6-9622-3164B291ECBFQ35271987-57E1F826-D831-49E6-9B81-D4E00FEC9C94Q36070394-F6714EA7-9D36-404B-8401-60292013428FQ36567517-99431FBF-29E5-419D-AC9F-5A0F6FDEB363Q36753621-F8B83DE1-6AC0-4204-BC80-5C9A69B90367Q36787493-CDA374B3-1E3F-4AB4-B304-DE29D4A336A1Q37247594-7360D522-AAB7-4055-90CC-001C39886E22Q37570464-A7958B5D-9D14-41B5-8AEF-41AFE1923229Q37783044-458AA698-0768-4B54-B5A2-907204B3857BQ38776368-462052F4-69D5-4C52-9D59-B3584EF0763DQ39781266-5D5E9F3B-0CD6-4830-BF14-D83CFBFC740DQ39781466-917FB32E-0859-4B24-81B3-14075CBBD63DQ39784283-8233D525-0837-4AF5-89E3-8FB0397FB8CDQ39785307-090ADE1A-B916-4B7C-979F-F91F4CF742D9Q39819064-F345C072-BD89-4317-9E24-9FFF9563437CQ39819129-41F9B15B-47B9-43D7-98AB-A00F54F713C7Q39866789-DE9EEB56-EDDC-4C97-9567-7CB37AA1A8C2
P2860
Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Toxicity of 3'-azido-3'-deoxyt ...... tic progenitor cells in vitro.
@ast
Toxicity of 3'-azido-3'-deoxyt ...... tic progenitor cells in vitro.
@en
type
label
Toxicity of 3'-azido-3'-deoxyt ...... tic progenitor cells in vitro.
@ast
Toxicity of 3'-azido-3'-deoxyt ...... tic progenitor cells in vitro.
@en
prefLabel
Toxicity of 3'-azido-3'-deoxyt ...... tic progenitor cells in vitro.
@ast
Toxicity of 3'-azido-3'-deoxyt ...... tic progenitor cells in vitro.
@en
P2860
P356
P1476
Toxicity of 3'-azido-3'-deoxyt ...... tic progenitor cells in vitro.
@en
P2093
J P Sommadossi
R Carlisle
P2860
P304
P356
10.1128/AAC.31.3.452
P407
P577
1987-03-01T00:00:00Z